CARGO Therapeutics Statistics

Total Valuation

CRGX has a market cap or net worth of $727.70 million. The enterprise value is $351.89 million.

Market Cap	727.70M
Enterprise Value	351.89M

Important Dates

The last earnings date was Tuesday, November 12, 2024, after market close.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

CRGX has 46.03 million shares outstanding. The number of shares has increased by 5,912.46% in one year.

Current Share Class	46.03M
Shares Outstanding	46.03M
Shares Change (YoY)	+5,912.46%
Shares Change (QoQ)	+9.97%
Owned by Insiders (%)	0.39%
Owned by Institutions (%)	77.64%
Float	31.01M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	1.81
P/TBV Ratio	1.82
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 18.95, with a Debt / Equity ratio of 0.07.

Current Ratio	18.95
Quick Ratio	18.84
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -69.81% and return on invested capital (ROIC) is -45.50%.

Return on Equity (ROE)	-69.81%
Return on Assets (ROA)	-40.35%
Return on Capital (ROIC)	-45.50%
Revenue Per Employee	n/a
Profits Per Employee	-$1.33M
Employee Count	116
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +9.69% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+9.69%
50-Day Moving Average	20.11
200-Day Moving Average	19.91
Relative Strength Index (RSI)	34.07
Average Volume (20 Days)	192,878

Short Selling Information

The latest short interest is 5.57 million, so 12.10% of the outstanding shares have been sold short.

Short Interest	5.57M
Short Previous Month	5.43M
Short % of Shares Out	12.10%
Short % of Float	17.97%
Short Ratio (days to cover)	31.64

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-172.19M
Pretax Income	n/a
Net Income	-154.14M
EBITDA	-169.79M
EBIT	-172.19M
Earnings Per Share (EPS)	-$4.01

Full Income Statement

Balance Sheet

The company has $404.85 million in cash and $28.58 million in debt, giving a net cash position of $376.26 million or $8.17 per share.

Cash & Cash Equivalents	404.85M
Total Debt	28.58M
Net Cash	376.26M
Net Cash Per Share	$8.17
Equity (Book Value)	400.88M
Book Value Per Share	8.72
Working Capital	388.38M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$133.84 million and capital expenditures -$6.43 million, giving a free cash flow of -$140.27 million.

Operating Cash Flow	-133.84M
Capital Expenditures	-6.43M
Free Cash Flow	-140.27M
FCF Per Share	-$3.05

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

CRGX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-5,912.46%
Shareholder Yield	-5,912.46%
Earnings Yield	-21.17%
FCF Yield	-19.26%

Analyst Forecast

The average price target for CRGX is $30.33, which is 91.84% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$30.33
Price Target Difference	91.84%
Analyst Consensus	Strong Buy
Analyst Count	7
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	2